SlideShare a Scribd company logo
Inflammatory Bowel Disease
Lara Masri
PPU
Crohn Disease
Crohn disease is a chronic transmural inflammatory disease that can affect any part of the
GI tract (mouth to anus) but most commonly involves the small bowel (terminal ileum).
Distribution: There are three major patterns of disease:
a. 40% have disease in the terminal ileum and cecum.
b. 30% have disease confined to the small intestine.
c. 20% have disease confined to the colon.
d. Rarely, other parts of GI tract may be involved (stomach, mouth, esophagus)
Sex: ♂ = ♀
Typical age of onset: bimodal distribution with one peak at 15–35 years and another one
at 55–70 years
Risk factors
• Familial aggregation
• Genetic predisposition (e.g., mutation of the NOD2 gene, HLA B27 association)
• Tobacco smoke
Pathology
a. Terminal ileum is the hallmark location, but other sites of GI tract may also be
involved.
b. Skip lesions—discontinuous involvement
c. Fistulae
d. Luminal strictures
e. Noncaseating granulomas
f. Transmural thickening and inflammation (full-thickness wall involvement)—
results in narrowing of the lumen.
g. Mesenteric “fat creeping” onto the antimesenteric border of small bowel.
h. Cobblestones appearnace
c/p:
Constitutional symptoms : Low-grade fever, Weight loss, Fatigue
Gastrointestinal symptoms : CD most commonly affects the terminal ileum
and colon, but involvement of any part of the GI tract (from mouth to anus) is
possible. In contrast to ulcerative colitis, rectal involvement is uncommon.
1. Chronic diarrhea
2. Lower gastrointestinal bleeding (uncommon)
3. Abdominal pain, typically in the RLQ
4. Palpable abdominal mass in the RLQ
5. Features of CD complications
• Malabsorption (e.g., weight loss, anemia, failure to thrive)
• Enterocutaneous or perianal fistulas, often associated with abscess
formation
Extraintestinal symptoms
• Joints: Enteropathic arthritis, Nail clubbing
• Eyes: Uveitis, Iritis, Episcleritis
• Liver/bile ducts: cholelithiasis
• Urogenital system: urolithiasis (mostly calcium oxalate stones)
• Oral mucosa: Oral aphthae, Pyostomatitis vegetans
• Skin: Erythema nodosum, Pyoderma gangrenosum
Diagnosis
1. Endoscopy (sigmoidoscopy or colonoscopy) with biopsy—typical
findings are aphthous ulcers, cobblestone appearance,
pseudopolyps, patchy (skip) lesions.
2. Barium enema
Complications
1. Fistulae—between colon and other segments of intestine (enteroenteral), bladder
(enterovesical), vagina (enterovaginal), and skin (enterocutaneous)
2. Anorectal disease (in 30% of patients)—fissures, abscesses, perianal fistulas
3. SBO (in 20% to 30% of patients) is the most common indication for surgery.
4. Malignancy—increased risk of colonic and small bowel tumors (but less common
than risk of malignancy in UC).
5. Malabsorption of vitamin B12 and bile acids (both occur in terminal ileum).
6. Cholelithiasis may occur secondary to decreased bile acid absorption.
7. Nephrolithiasis—increased colonic absorption of dietary oxalate can lead to calcium
oxalate kidney stones.
8. Aphthous ulcers of lips, gingiva, and buccal mucosa (common)
9. Toxic megacolon—less common in Crohn disease than in UC
10. Growth retardation
Ulcerative Colitis
• UC is a chronic inflammatory disease of the colon or rectal mucosa.
• It may occur at any age (usually begins in adolescence or young adulthood).
• Distribution: UC involves the rectum in all cases and can involve the colon either partially
or entirely, but is always continuous. There are no skip lesions as are seen in Crohn
disease.
1. Rectum alone (in 10% of cases)
2. Rectum and left colon (in 40% of cases)
3. Rectum, left colon, and right colon (in 30% of cases)
4. Pancolitis (in 30% of cases)
5. The small bowel is not usually involved in UC, but it may reach the distal ileum
in a small percentage of patients (“backwash ileitis” in 10% of cases)
• characterized by periodic exacerbations and periods of complete remission. Less than 5%
of patients have an initial attack without any recurrence.
Pathology
a. Uninterrupted involvement of rectum and/or colon
b. Inflammation is not transmural (as it is in Crohn disease). It is limited to the mucosa and
submucosa.
c. PMNs accumulate in the crypts of the colon causing crypt abscesses.
Clinical Features (wide ranges of presentation are seen)
1. Hematochezia (bloody diarrhea)
2. Abdominal pain
3. Bowel movements are frequent but small
4. Fever, anorexia, and weight loss (severe cases)
5. Tenesmus (rectal dry heaves)
6. Extraintestinal symptoms : mainly 1° sclerosing cholangitis. Associated with MPO
ANCA/p-ANCA.
Diagnosis: perform the following initial studies
1. Stool cultures for Clostridium difficile, ova, and parasites to rule out infectious
diarrhea.
2. Fecal leukocytes a. WBCs can appear in UC, ischemic colitis, or infectious diarrhea.
3. Colonoscopy to assess the extent of disease and the presence of any complications
Complications
1. Iron deficiency anemia
2. Hemorrhage
3. Electrolyte disturbances and dehydration secondary to diarrhea
4. Strictures, benign and malignant (usually malignant)
5. Colon cancer—The risk correlates with extent and duration of colitis. In distal
proctitis there is no increased risk of CRC.
6. Sclerosing cholangitis (SC)—Does not correlate with bowel disease and is not
prevented by colectomy.
7. Cholangiocarcinoma—Half of all bile duct cancers are associated with UC
8. Toxic megacolon is the leading cause of death in UC and affects <5% of patients.
It is associated with the risk of colonic perforation.
9. Growth retardation
10. Narcotic abuse
11. Psychosocial issues (e.g., depression) due to chronicity and often disabling nature
of the disease
Inflammatory Bowel Disease.pptx

More Related Content

Similar to Inflammatory Bowel Disease.pptx

abdominaltuberculosis
abdominaltuberculosisabdominaltuberculosis
abdominaltuberculosis
afzal mohd
 
Gastrointestinal & Hepatobiliary System
Gastrointestinal & Hepatobiliary SystemGastrointestinal & Hepatobiliary System
Gastrointestinal & Hepatobiliary System
Rozzan Khatiwada
 
Git ibd 2012 pretest.
Git ibd 2012 pretest.Git ibd 2012 pretest.
Git ibd 2012 pretest.
Shaikhani.
 
E570 abdominal tuberculosis
E570 abdominal tuberculosisE570 abdominal tuberculosis
E570 abdominal tuberculosis
Afrina Qureshi
 
Abdominal Tuberculosis
Abdominal TuberculosisAbdominal Tuberculosis
Abdominal Tuberculosis
NAVANEETA KUSUM
 
GASTROINTESTINAL PATHOLOGY
GASTROINTESTINAL PATHOLOGY GASTROINTESTINAL PATHOLOGY
GASTROINTESTINAL PATHOLOGY
Dr Yaseen Khan
 
Inflammatory bowel disease- Lower gi hemorrhage
Inflammatory bowel disease-  Lower gi hemorrhageInflammatory bowel disease-  Lower gi hemorrhage
Inflammatory bowel disease- Lower gi hemorrhage
Selvaraj Balasubramani
 
Tropical disease
Tropical diseaseTropical disease
Tropical disease
surgerymgmcri
 
Inflammatory Bowel Diseases (IBD)
Inflammatory Bowel Diseases (IBD)Inflammatory Bowel Diseases (IBD)
Inflammatory Bowel Diseases (IBD)
Abdulgadir Almograby
 
Abdominal Tuberculosis
Abdominal TuberculosisAbdominal Tuberculosis
Abdominal Tuberculosis
Prateek Kumar
 
Gastric disorder
Gastric disorderGastric disorder
Gastric disorder
Mohanad Mohanad
 
CME LGIB.pptx
CME LGIB.pptxCME LGIB.pptx
CME LGIB.pptx
sindhubapoo1
 
Crohn’s disease
Crohn’s diseaseCrohn’s disease
Crohn’s disease
diana tabansi
 
Lecture diseases of the git
Lecture diseases of the gitLecture diseases of the git
Lecture diseases of the git
luciferahamed
 
L13 inflammatory bowel disease f
L13 inflammatory bowel disease fL13 inflammatory bowel disease f
L13 inflammatory bowel disease f
Mohammad Manzoor
 
Bohomolets Surgery 4th year Lecture #8
Bohomolets Surgery 4th year Lecture #8Bohomolets Surgery 4th year Lecture #8
Bohomolets Surgery 4th year Lecture #8
Dr. Rubz
 
Dysentery
DysenteryDysentery
Dysentery
Dr. Faisal Khan
 
Inflammatory bowel disease
Inflammatory bowel diseaseInflammatory bowel disease
Inflammatory bowel disease
THUSHARA MOHAN
 
abdominal tuberculosis
abdominal tuberculosisabdominal tuberculosis
abdominal tuberculosis
Afrina Qureshi
 
GASTRO INTESTINAL TRACT LYMPHOMAS AND PET CT
GASTRO INTESTINAL TRACT LYMPHOMAS AND PET CTGASTRO INTESTINAL TRACT LYMPHOMAS AND PET CT
GASTRO INTESTINAL TRACT LYMPHOMAS AND PET CT
Arif S
 

Similar to Inflammatory Bowel Disease.pptx (20)

abdominaltuberculosis
abdominaltuberculosisabdominaltuberculosis
abdominaltuberculosis
 
Gastrointestinal & Hepatobiliary System
Gastrointestinal & Hepatobiliary SystemGastrointestinal & Hepatobiliary System
Gastrointestinal & Hepatobiliary System
 
Git ibd 2012 pretest.
Git ibd 2012 pretest.Git ibd 2012 pretest.
Git ibd 2012 pretest.
 
E570 abdominal tuberculosis
E570 abdominal tuberculosisE570 abdominal tuberculosis
E570 abdominal tuberculosis
 
Abdominal Tuberculosis
Abdominal TuberculosisAbdominal Tuberculosis
Abdominal Tuberculosis
 
GASTROINTESTINAL PATHOLOGY
GASTROINTESTINAL PATHOLOGY GASTROINTESTINAL PATHOLOGY
GASTROINTESTINAL PATHOLOGY
 
Inflammatory bowel disease- Lower gi hemorrhage
Inflammatory bowel disease-  Lower gi hemorrhageInflammatory bowel disease-  Lower gi hemorrhage
Inflammatory bowel disease- Lower gi hemorrhage
 
Tropical disease
Tropical diseaseTropical disease
Tropical disease
 
Inflammatory Bowel Diseases (IBD)
Inflammatory Bowel Diseases (IBD)Inflammatory Bowel Diseases (IBD)
Inflammatory Bowel Diseases (IBD)
 
Abdominal Tuberculosis
Abdominal TuberculosisAbdominal Tuberculosis
Abdominal Tuberculosis
 
Gastric disorder
Gastric disorderGastric disorder
Gastric disorder
 
CME LGIB.pptx
CME LGIB.pptxCME LGIB.pptx
CME LGIB.pptx
 
Crohn’s disease
Crohn’s diseaseCrohn’s disease
Crohn’s disease
 
Lecture diseases of the git
Lecture diseases of the gitLecture diseases of the git
Lecture diseases of the git
 
L13 inflammatory bowel disease f
L13 inflammatory bowel disease fL13 inflammatory bowel disease f
L13 inflammatory bowel disease f
 
Bohomolets Surgery 4th year Lecture #8
Bohomolets Surgery 4th year Lecture #8Bohomolets Surgery 4th year Lecture #8
Bohomolets Surgery 4th year Lecture #8
 
Dysentery
DysenteryDysentery
Dysentery
 
Inflammatory bowel disease
Inflammatory bowel diseaseInflammatory bowel disease
Inflammatory bowel disease
 
abdominal tuberculosis
abdominal tuberculosisabdominal tuberculosis
abdominal tuberculosis
 
GASTRO INTESTINAL TRACT LYMPHOMAS AND PET CT
GASTRO INTESTINAL TRACT LYMPHOMAS AND PET CTGASTRO INTESTINAL TRACT LYMPHOMAS AND PET CT
GASTRO INTESTINAL TRACT LYMPHOMAS AND PET CT
 

More from Lara Masri

Renal tumors.pptx
Renal tumors.pptxRenal tumors.pptx
Renal tumors.pptx
Lara Masri
 
Tachyarrhythmia l.pptx
Tachyarrhythmia l.pptxTachyarrhythmia l.pptx
Tachyarrhythmia l.pptx
Lara Masri
 
lung cancer.pptx
lung cancer.pptxlung cancer.pptx
lung cancer.pptx
Lara Masri
 
thyroid nodules and cancer.pptx
thyroid nodules and cancer.pptxthyroid nodules and cancer.pptx
thyroid nodules and cancer.pptx
Lara Masri
 
Chronic-complication-of-DM.pptx
Chronic-complication-of-DM.pptxChronic-complication-of-DM.pptx
Chronic-complication-of-DM.pptx
Lara Masri
 
Vomiting.pptx
Vomiting.pptxVomiting.pptx
Vomiting.pptx
Lara Masri
 
Jugular Venous Pulse (JVP).pptx
Jugular Venous Pulse (JVP).pptxJugular Venous Pulse (JVP).pptx
Jugular Venous Pulse (JVP).pptx
Lara Masri
 
Scleroderma.pptx
Scleroderma.pptxScleroderma.pptx
Scleroderma.pptx
Lara Masri
 
PCKD.pptx
PCKD.pptxPCKD.pptx
PCKD.pptx
Lara Masri
 
cataract surgery.pptx
cataract surgery.pptxcataract surgery.pptx
cataract surgery.pptx
Lara Masri
 
Late Pregnancy Bleeding.pptx
Late Pregnancy Bleeding.pptxLate Pregnancy Bleeding.pptx
Late Pregnancy Bleeding.pptx
Lara Masri
 
abnormal vaginal bleeding.pptx
abnormal vaginal bleeding.pptxabnormal vaginal bleeding.pptx
abnormal vaginal bleeding.pptx
Lara Masri
 
ovarian and uterine tumors.pptx
ovarian and uterine tumors.pptxovarian and uterine tumors.pptx
ovarian and uterine tumors.pptx
Lara Masri
 

More from Lara Masri (13)

Renal tumors.pptx
Renal tumors.pptxRenal tumors.pptx
Renal tumors.pptx
 
Tachyarrhythmia l.pptx
Tachyarrhythmia l.pptxTachyarrhythmia l.pptx
Tachyarrhythmia l.pptx
 
lung cancer.pptx
lung cancer.pptxlung cancer.pptx
lung cancer.pptx
 
thyroid nodules and cancer.pptx
thyroid nodules and cancer.pptxthyroid nodules and cancer.pptx
thyroid nodules and cancer.pptx
 
Chronic-complication-of-DM.pptx
Chronic-complication-of-DM.pptxChronic-complication-of-DM.pptx
Chronic-complication-of-DM.pptx
 
Vomiting.pptx
Vomiting.pptxVomiting.pptx
Vomiting.pptx
 
Jugular Venous Pulse (JVP).pptx
Jugular Venous Pulse (JVP).pptxJugular Venous Pulse (JVP).pptx
Jugular Venous Pulse (JVP).pptx
 
Scleroderma.pptx
Scleroderma.pptxScleroderma.pptx
Scleroderma.pptx
 
PCKD.pptx
PCKD.pptxPCKD.pptx
PCKD.pptx
 
cataract surgery.pptx
cataract surgery.pptxcataract surgery.pptx
cataract surgery.pptx
 
Late Pregnancy Bleeding.pptx
Late Pregnancy Bleeding.pptxLate Pregnancy Bleeding.pptx
Late Pregnancy Bleeding.pptx
 
abnormal vaginal bleeding.pptx
abnormal vaginal bleeding.pptxabnormal vaginal bleeding.pptx
abnormal vaginal bleeding.pptx
 
ovarian and uterine tumors.pptx
ovarian and uterine tumors.pptxovarian and uterine tumors.pptx
ovarian and uterine tumors.pptx
 

Recently uploaded

Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
arahmanzai5
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
rightmanforbloodline
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 

Recently uploaded (20)

Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 

Inflammatory Bowel Disease.pptx

  • 2.
  • 3. Crohn Disease Crohn disease is a chronic transmural inflammatory disease that can affect any part of the GI tract (mouth to anus) but most commonly involves the small bowel (terminal ileum). Distribution: There are three major patterns of disease: a. 40% have disease in the terminal ileum and cecum. b. 30% have disease confined to the small intestine. c. 20% have disease confined to the colon. d. Rarely, other parts of GI tract may be involved (stomach, mouth, esophagus) Sex: ♂ = ♀ Typical age of onset: bimodal distribution with one peak at 15–35 years and another one at 55–70 years Risk factors • Familial aggregation • Genetic predisposition (e.g., mutation of the NOD2 gene, HLA B27 association) • Tobacco smoke
  • 4. Pathology a. Terminal ileum is the hallmark location, but other sites of GI tract may also be involved. b. Skip lesions—discontinuous involvement c. Fistulae d. Luminal strictures e. Noncaseating granulomas f. Transmural thickening and inflammation (full-thickness wall involvement)— results in narrowing of the lumen. g. Mesenteric “fat creeping” onto the antimesenteric border of small bowel. h. Cobblestones appearnace
  • 5. c/p: Constitutional symptoms : Low-grade fever, Weight loss, Fatigue Gastrointestinal symptoms : CD most commonly affects the terminal ileum and colon, but involvement of any part of the GI tract (from mouth to anus) is possible. In contrast to ulcerative colitis, rectal involvement is uncommon. 1. Chronic diarrhea 2. Lower gastrointestinal bleeding (uncommon) 3. Abdominal pain, typically in the RLQ 4. Palpable abdominal mass in the RLQ 5. Features of CD complications • Malabsorption (e.g., weight loss, anemia, failure to thrive) • Enterocutaneous or perianal fistulas, often associated with abscess formation
  • 6. Extraintestinal symptoms • Joints: Enteropathic arthritis, Nail clubbing • Eyes: Uveitis, Iritis, Episcleritis • Liver/bile ducts: cholelithiasis • Urogenital system: urolithiasis (mostly calcium oxalate stones) • Oral mucosa: Oral aphthae, Pyostomatitis vegetans • Skin: Erythema nodosum, Pyoderma gangrenosum Diagnosis 1. Endoscopy (sigmoidoscopy or colonoscopy) with biopsy—typical findings are aphthous ulcers, cobblestone appearance, pseudopolyps, patchy (skip) lesions. 2. Barium enema
  • 7. Complications 1. Fistulae—between colon and other segments of intestine (enteroenteral), bladder (enterovesical), vagina (enterovaginal), and skin (enterocutaneous) 2. Anorectal disease (in 30% of patients)—fissures, abscesses, perianal fistulas 3. SBO (in 20% to 30% of patients) is the most common indication for surgery. 4. Malignancy—increased risk of colonic and small bowel tumors (but less common than risk of malignancy in UC). 5. Malabsorption of vitamin B12 and bile acids (both occur in terminal ileum). 6. Cholelithiasis may occur secondary to decreased bile acid absorption. 7. Nephrolithiasis—increased colonic absorption of dietary oxalate can lead to calcium oxalate kidney stones. 8. Aphthous ulcers of lips, gingiva, and buccal mucosa (common) 9. Toxic megacolon—less common in Crohn disease than in UC 10. Growth retardation
  • 8.
  • 9. Ulcerative Colitis • UC is a chronic inflammatory disease of the colon or rectal mucosa. • It may occur at any age (usually begins in adolescence or young adulthood). • Distribution: UC involves the rectum in all cases and can involve the colon either partially or entirely, but is always continuous. There are no skip lesions as are seen in Crohn disease. 1. Rectum alone (in 10% of cases) 2. Rectum and left colon (in 40% of cases) 3. Rectum, left colon, and right colon (in 30% of cases) 4. Pancolitis (in 30% of cases) 5. The small bowel is not usually involved in UC, but it may reach the distal ileum in a small percentage of patients (“backwash ileitis” in 10% of cases) • characterized by periodic exacerbations and periods of complete remission. Less than 5% of patients have an initial attack without any recurrence.
  • 10. Pathology a. Uninterrupted involvement of rectum and/or colon b. Inflammation is not transmural (as it is in Crohn disease). It is limited to the mucosa and submucosa. c. PMNs accumulate in the crypts of the colon causing crypt abscesses.
  • 11. Clinical Features (wide ranges of presentation are seen) 1. Hematochezia (bloody diarrhea) 2. Abdominal pain 3. Bowel movements are frequent but small 4. Fever, anorexia, and weight loss (severe cases) 5. Tenesmus (rectal dry heaves) 6. Extraintestinal symptoms : mainly 1° sclerosing cholangitis. Associated with MPO ANCA/p-ANCA. Diagnosis: perform the following initial studies 1. Stool cultures for Clostridium difficile, ova, and parasites to rule out infectious diarrhea. 2. Fecal leukocytes a. WBCs can appear in UC, ischemic colitis, or infectious diarrhea. 3. Colonoscopy to assess the extent of disease and the presence of any complications
  • 12. Complications 1. Iron deficiency anemia 2. Hemorrhage 3. Electrolyte disturbances and dehydration secondary to diarrhea 4. Strictures, benign and malignant (usually malignant) 5. Colon cancer—The risk correlates with extent and duration of colitis. In distal proctitis there is no increased risk of CRC. 6. Sclerosing cholangitis (SC)—Does not correlate with bowel disease and is not prevented by colectomy. 7. Cholangiocarcinoma—Half of all bile duct cancers are associated with UC 8. Toxic megacolon is the leading cause of death in UC and affects <5% of patients. It is associated with the risk of colonic perforation. 9. Growth retardation 10. Narcotic abuse 11. Psychosocial issues (e.g., depression) due to chronicity and often disabling nature of the disease